{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:21:12Z","timestamp":1761060072318},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,2,23]]},"DOI":"10.18632\/oncotarget.7072","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T13:27:24Z","timestamp":1454074044000},"page":"9550-9560","source":"Crossref","is-referenced-by-count":8,"title":["A TET2 rs3733609 C\/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2V617F and confers a proliferative potential on erythroid lineages"],"prefix":"10.18632","volume":"7","author":[{"given":"Xiao-hui","family":"Shen","sequence":"first","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-nan","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-fei","family":"Yin","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-fang","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-liu","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-ling","family":"Peng","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-wen","family":"Dai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-xiao","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-yang","family":"Deng","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-ya","family":"Luo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-li","family":"Zheng","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-sen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.18632\/oncotarget.281","article-title":"Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies","volume":"2","author":"Cazzola","year":"2011","journal-title":"Oncotarget"},{"key":"2","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2014-03-530865","article-title":"From Janus kinase 2 to calreticulin: The clinically relevant genomic landscape of myeloproliferative neoplasms","volume":"123","author":"Kralovic","year":"2014","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Skoda","year":"2005","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"Casadevall","year":"2005","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2040620713489144","article-title":"Inherited predisposition to myeloproliferative neoplasms","volume":"4","author":"Cross","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2008-01-131664","article-title":"MPL mutations in myeloproliferative disorders: Analysis of the PT-1 cohort","volume":"112","author":"Harrison","year":"2008","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with non mutated JAK2","volume":"369","author":"Hinton","year":"2013","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Bagienski","year":"2013","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2007.12.6896","article-title":"Familial chronic myeloproliferative disorders:Clinical phenotype and evidence of disease anticipation","volume":"25","author":"Lazzarino","year":"2007","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2014-01-550434","article-title":"CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis","volume":"123","author":"Boveri","year":"2014","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Cross","year":"2009","journal-title":"Nat Genet"},{"key":"12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms","volume":"41","author":"Stone","year":"2009","journal-title":"Nat Genet"},{"key":"13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3324\/haematol.2010.034488","article-title":"The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms","volume":"96","author":"Kralovics","year":"2011","journal-title":"Haematologica"},{"key":"14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/leu.2014.48","article-title":"The germline sequence variant rs2736100-C in TERT associates with myeloproliferative neoplasms","volume":"28","author":"Olafsson","year":"2014","journal-title":"Leukemia"},{"key":"15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ajh.23842","article-title":"Common germline variation at the TERT locus contributes to familial clusting of myeloproliferative neoplasms","volume":"89","author":"Kralovics","year":"2014","journal-title":"Am J Hematol"},{"key":"16","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1182\/blood-2007-06-095703","article-title":"Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders","volume":"111","author":"Tefferi","year":"2008","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Dreyfus","year":"2009","journal-title":"N Engl J Med"},{"key":"18","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/leu.2009.141","article-title":"Mutations of ASXL1 gene in myeloproliferative neoplasms","volume":"23","author":"Mozziconacci","year":"2009","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myeloidysplastic syndromes","volume":"41","author":"Verburgh","year":"2009","journal-title":"Nat Genet"},{"key":"20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/gcc.21960","article-title":"Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms","volume":"51","author":"Vey","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2012.02.028","article-title":"Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm","volume":"148","author":"Ye","year":"2012","journal-title":"Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.hoc.2012.07.006","article-title":"Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms","volume":"26","author":"Levine","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/leu.2009.47","article-title":"TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis","volume":"23","author":"Mesa","year":"2009","journal-title":"Leukemia"},{"key":"24","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00277-014-2134-9","article-title":"The JAK2 46\/1 haplotype (GGCC) in myeloproliferative neoplasms and splanchnic vein thrombosis: a pooled analysis of 26 observational studies","volume":"93","author":"Lu","year":"2014","journal-title":"Ann Hematol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Bhatt","year":"2012","journal-title":"Nat Genet"},{"key":"26","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3109\/10428194.2013.778408","article-title":"Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes","volume":"54","author":"Shen","year":"2013","journal-title":"Leukemia & Lymphoma"},{"key":"27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/85820","article-title":"Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBPalpha) in acute myeloid leukemia","volume":"27","author":"Tenen","year":"2001","journal-title":"Nat Genet"},{"key":"28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12185-010-0573-1","article-title":"Molecular mechanisms underlying deregulation of C\/EBPalpha in acute myeloid leukemia","volume":"91","author":"Cammenga","year":"2010","journal-title":"Int J Hematol"},{"key":"29","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Vardiman","year":"2008","journal-title":"International agency for research on cancer, world health organization"},{"key":"30","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Wideespread occurrence of JAK2V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Loukopoulos","year":"2005","journal-title":"Blood"},{"key":"31","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1091\/mbc.e10-01-0040","article-title":"ZFP36L1 Negatively Regulates Erythroid Differentiation of CD34+Hematopoietic Stem Cells by Interfering with the Stat5b Pathway","volume":"21","author":"Ferrari","year":"2010","journal-title":"Mol Biol Cell"},{"key":"32","first-page":"257","article-title":"A, microccytofluorometric method for aquantitive and qualitative evaluation of CFU-E and BFU-E colonies","volume":"94","author":"Fujita","year":"1990","journal-title":"Hisoc hemistry"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:02:42Z","timestamp":1589220162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2,23]]}},"alternative-id":["7072","26843622"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7072","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}